360 related articles for article (PubMed ID: 10737897)
1. Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras.
Tokumitsu Y; Nakano S; Ueno H; Niho Y
J Cell Physiol; 2000 May; 183(2):221-7. PubMed ID: 10737897
[TBL] [Abstract][Full Text] [Related]
2. R-Ras promotes tumor growth of cervical epithelial cells.
Rincón-Arano H; Rosales R; Mora N; Rodriguez-Castañeda A; Rosales C
Cancer; 2003 Feb; 97(3):575-85. PubMed ID: 12548599
[TBL] [Abstract][Full Text] [Related]
3. An anti-Ras cancer potential of PP1, an inhibitor specific for Src family kinases: in vitro and in vivo studies.
He H; Hirokawa Y; Levitzki A; Maruta H
Cancer J; 2000; 6(4):243-8. PubMed ID: 11038144
[TBL] [Abstract][Full Text] [Related]
4. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
Ulkü AS; Schäfer R; Der CJ
Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
[TBL] [Abstract][Full Text] [Related]
5. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K
Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717
[TBL] [Abstract][Full Text] [Related]
6. RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases.
Aguirre-Ghiso JA; Frankel P; Farias EF; Lu Z; Jiang H; Olsen A; Feig LA; de Kier Joffe EB; Foster DA
Oncogene; 1999 Aug; 18(33):4718-25. PubMed ID: 10467419
[TBL] [Abstract][Full Text] [Related]
7. Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis.
Lin X; Gelman IH
Cancer Res; 1997 Jun; 57(11):2304-12. PubMed ID: 9187136
[TBL] [Abstract][Full Text] [Related]
8. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
9. Ras, but not Src, transformation of RIE-1 epithelial cells is dependent on activation of the mitogen-activated protein kinase cascade.
Oldham SM; Cox AD; Reynolds ER; Sizemore NS; Coffey RJ; Der CJ
Oncogene; 1998 May; 16(20):2565-73. PubMed ID: 9632133
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
[TBL] [Abstract][Full Text] [Related]
11. Direct tumorigenic conversion of human gallbladder carcinoma cells by v-src but not by activated c-H-ras oncogene.
Tatsumoto T; Nakano S; Shimizu K; Ono M; Esaki T; Ohshima K; Niho Y
Int J Cancer; 1995 Apr; 61(2):206-13. PubMed ID: 7705949
[TBL] [Abstract][Full Text] [Related]
12. Src tyrosine kinase but not activated Ras augments sensitivity to taxanes through apoptosis in human adenocarcinoma cells.
Boudny V; Nakano S
Anticancer Res; 2003; 23(1A):7-12. PubMed ID: 12680188
[TBL] [Abstract][Full Text] [Related]
13. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
14. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
Du J; Jiang B; Coffey RJ; Barnard J
Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
[TBL] [Abstract][Full Text] [Related]
15. A role for Ras in v-Crk transformation.
Greulich H; Hanafusa H
Cell Growth Differ; 1996 Nov; 7(11):1443-51. PubMed ID: 8930393
[TBL] [Abstract][Full Text] [Related]
16. [Inhibition of ras-dependent transformation by using dominant negative ras mutant N116Y].
Yokoyama T
Hokkaido Igaku Zasshi; 1995 May; 70(3):459-71. PubMed ID: 7590597
[TBL] [Abstract][Full Text] [Related]
17. Multiple aspects of the phenotype of mammary epithelial cells transformed by expression of activated M-Ras depend on an autocrine mechanism mediated by hepatocyte growth factor/scatter factor.
Zhang KX; Ward KR; Schrader JW
Mol Cancer Res; 2004 Apr; 2(4):242-55. PubMed ID: 15140946
[TBL] [Abstract][Full Text] [Related]
18. Silencing of N-Ras gene expression using shRNA decreases transformation efficiency and tumor growth in transformed cells induced by anti-BPDE.
Zhou L; Jiang Y; Tan A; Greenlee AR; Shen Y; Liu L; Yang Q
Toxicol Sci; 2008 Oct; 105(2):286-94. PubMed ID: 18567617
[TBL] [Abstract][Full Text] [Related]
19. Malolactomycin D, a potent inhibitor of transcription controlled by the Ras responsive element, inhibits Ras-mediated transformation activity with suppression of MMP-1 and MMP-9 in NIH3T3 cells.
Futamura M; Kamiya S; Tsukamoto M; Hirano A; Monden Y; Arakawa H; Nishimura S
Oncogene; 2001 Oct; 20(46):6724-30. PubMed ID: 11709707
[TBL] [Abstract][Full Text] [Related]
20. Delineating v-Src downstream effector pathways in transformed myoblasts.
Ciuffini L; Castellani L; Salvati E; Galletti S; Falcone G; Alemà S
Oncogene; 2008 Jan; 27(4):528-39. PubMed ID: 17637741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]